Kepler Universitätskliniken GmbH - Med Campus III; Neurologie & Psychiatrie
About Kepler Universitätskliniken GmbH - Med Campus III; Neurologie & Psychiatrie
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
3
Clinical Trials at Kepler Universitätskliniken GmbH - Med Campus III; Neurologie & Psychiatrie
During the past decade, Kepler Universitätskliniken GmbH - Med Campus III; Neurologie & Psychiatrie conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on
average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
2011-03-02
2022-12-31
Completed
735
Non-interventional Study of Ocrelizumab in Participants With Relapsing or Primary Progressive Multiple Sclerosis
2018-11-12
2025-07-26
Active, not recruiting
1,700
Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Teriflunomide in Relapsing Multiple Sclerosis (RMS)
2021-03-24
2025-11-27
Recruiting
736
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Kepler Universitätskliniken GmbH - Med Campus III; Neurologie & Psychiatrie
According to Clinical.Site data, the most researched conditions in "Kepler Universitätskliniken GmbH - Med Campus III; Neurologie & Psychiatrie" are
"Multiple Sclerosis" (1 trials), "Multiple Sclerosis, Primary Progressive" (1 trials) and "Relapsing Multiple Sclerosis" (1 trials). Many other conditions were trialed in "Kepler Universitätskliniken GmbH - Med Campus III; Neurologie & Psychiatrie" in a lesser frequency.
Clinical Trials Intervention Types at Kepler Universitätskliniken GmbH - Med Campus III; Neurologie & Psychiatrie
Most popular intervention types in "Kepler Universitätskliniken GmbH - Med Campus III; Neurologie & Psychiatrie" are "Drug" (3 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Ocrelizumab" (2 trials), "Placebo" (2 trials), "Fenebrutinib" (1 trials) and "Teriflunomide" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Kepler Universitätskliniken GmbH - Med Campus III; Neurologie & Psychiatrie
The vast majority of trials in "Kepler Universitätskliniken GmbH - Med Campus III; Neurologie & Psychiatrie" are
3 trials for "All" genders.
Clinical Trials Status at Kepler Universitätskliniken GmbH - Med Campus III; Neurologie & Psychiatrie
Currently, there are NaN active trials in "Kepler Universitätskliniken GmbH - Med Campus III; Neurologie & Psychiatrie".
undefined are not yet recruiting,
1 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in Kepler Universitätskliniken GmbH - Med Campus III; Neurologie & Psychiatrie,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Kepler Universitätskliniken GmbH - Med Campus III; Neurologie & Psychiatrie, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".